Hantz Financial Services, Inc. Dexcom Inc Transaction History

Hantz Financial Services, Inc.

$6.19 Billion
Q2 2025

A detailed history of Hantz Financial Services, Inc. transactions in Dexcom Inc stock. As of the latest transaction made, Hantz Financial Services, Inc. holds 100,779 shares of DXCM stock, worth $6.65 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares

100,779

Previous 113,526 11.23%

Holding current value

$6.65 Million

Previous $7.75 Million 13.47%

% of portfolio

0.14%

Previous 0.14%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 04, 2025	SELL	$59.83 - $87.57 $762,653 - $1.12 Million	-12,747 Reduced 11.23%	100,779 $8.8 Million
Q1 2025 May 12, 2025	SELL	$67.74 - $90.75 $173,753 - $232,773	-2,565 Reduced 2.21%	113,526 $7.75 Million
Q4 2024 Jan 23, 2025	BUY	$65.68 - $81.01 $7.57 Million - $9.33 Million	115,184 Added 12699.45%	116,091 $9.03 Million
Q3 2024 Nov 13, 2024	SELL	$64.0 - $116.06 $1.36 Million - $2.46 Million	-21,210 Reduced 95.9%	907 $61,000
Q2 2024 Jul 30, 2024	BUY	$110.31 - $140.45 $2.44 Million - $3.11 Million	22,117 New	22,117 $2.51 Million
Q1 2024 Aug 06, 2024	BUY	$114.22 - $140.1 $16,219 - $19,894	142 Added 0.66%	21,511 $2.98 Million
Q4 2023 Aug 06, 2024	BUY	$75.49 - $124.16 $259,912 - $427,482	3,443 Added 19.21%	21,369 $2.65 Million
Q3 2023 Aug 06, 2024	BUY	$86.06 - $137.93 $38,985 - $62,482	453 Added 2.59%	17,926 $1.67 Million
Q2 2023 Aug 06, 2024	BUY	$112.47 - $130.98 $31,041 - $36,150	276 Added 1.6%	17,473 $2.25 Million
Q1 2023 Aug 06, 2024	BUY	$104.0 - $122.92 $42,224 - $49,905	406 Added 2.42%	17,197 $2 Million
Q4 2022 Aug 06, 2024	BUY	$84.98 - $122.67 $84,300 - $121,688	992 Added 6.28%	16,791 $1.9 Million
Q3 2022 Aug 06, 2024	BUY	$76.35 - $94.18 $41,992 - $51,799	550 Added 3.61%	15,799 $1.27 Million
Q2 2022 Aug 06, 2024	BUY	$67.99 - $132.89 $833,761 - $1.63 Million	12,263 Added 410.68%	15,249 $1.14 Million
Q1 2022 Aug 06, 2024	BUY	$94.08 - $130.2 $48,168 - $66,662	512 Added 20.7%	2,986 $1.53 Million
Q4 2021 Aug 06, 2024	BUY	$129.87 - $162.82 $27,922 - $35,006	215 Added 9.52%	2,474 $1.33 Million
Q3 2021 Aug 06, 2024	BUY	$106.71 - $143.18 $57,089 - $76,601	535 Added 31.03%	2,259 $1.24 Million
Q2 2021 Aug 06, 2024	SELL	$80.99 - $107.93 $1.65 Million - $2.2 Million	-20,393 Reduced 92.21%	1,724 $736,000

Others Institutions Holding DXCM

# of Institutions

1,110

Shares Held

370M

Call Options Held

5.32M

Put Options Held

5.18M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $25.5B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hantz Financial Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hantz Financial Services, Inc. with notifications on news.

Account

Hantz Financial Services, Inc. Dexcom Inc Transaction History